Localization of a target region of allelic loss to a 1-cM interval on chromosome 16p.13.13 in hepatocellular carcinoma

Japanese Journal of Cancer Research

Volumn 90, Issue 9, 1999, Pages 951-956

  Koyama, Masaaki ^a,b   Nagai, Hisaki ^a   Bando, Koichi ^a   Ito, Masahide ^b   Moriyama, Yuukichi ^b   Emi, Mitsuru ^a  

^a Institute of Gerontology   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Chromosome 16p; Hepatocellular carcinoma; Loss of heterozygosity; Tumor suppressor gene

Indexed keywords

BINDING PROTEIN; CYTOKINE; MICROSATELLITE DNA;

ALLELE; ARTICLE; CANCER GENETICS; CANCER STAGING; CHROMOSOME 16P; CONTROLLED STUDY; DNA FLANKING REGION; GENE DELETION; GENE FREQUENCY; GENE INACTIVATION; GENE LOCUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MARKER GENE; NEGATIVE FEEDBACK; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0032706054     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00840.x     Document Type: Article

References (36)

1. Poynard, T., Bedossa, P., Opolon, P., for the OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet, 349, 825-832 (1997).
2. Okuda, K. Hepatocellular carcinoma: recent progress. Hepatology, 15, 948-963 (1992).
3. Matsubara, K. and Tokino, T. Integration of hepatitis B virus DNA and its implications for hepatocarcinogenesis. Mol. Biol. Med., 7, 243-260 (1990).
4. Wang, X. W. Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA, 91, 2230-2234 (1994).
5. Takada, S. Cytoplasmic retention of p53 tumor suppressor gene product is observed in the hepatitis B virus X genetransfected cells. Oncogene, 15, 1895-1901 (1997).
6. Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Nakamura, Y., White, R., Smits, A. M. and Bos, J. L. Genetic alterations during colorectal-tumor development. N. Engl. J. Med., 319, 525-532 (1998).
7. Knudson, A. G. Antioncogenes and human cancer. Proc. Natl. Acad Sci. USA, 90, 10914-10921 (1993).
8. Wang, H. P. and Rogler, C. E. Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas. Cytogenet. Cell Genet., 48, 72-78 (1988).
9. Buetow, K. H., Murray, J., Israel, J., London, W., Smith, M., Kew, M., Blanquet, V., Brechot, C., Redeker, A. and Govindarajah, S. Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinomas. Proc. Natl. Acad. Sci. USA, 89, 9622-9626 (1992).
10. Tsuda, H., Zang, W., Shimamoto, Y., Yokota, J., Terada, M., Sugimura, T., Miyamura, T. and Hirohashi, S. Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc. Natl Acad. Sci. USA, 87, 6791-6794 (1990).
11. Fujimori, M., Tokino, T., Hino, O., Kitagawa, T., Imamura, T., Okamoto, E., Mitsunobu, M., Ishikawa, T., Nakagawa, H., Harada, H., Yagura, M., Matsubara, K. and Nakamura, Y. Allelotype study of primary hepatocellular carcinoma. Cancer Res., 51, 89-93 (1991).
12. Emi, M., Fuziwara, Y., Nakajima, T., Tsuchiya, E., Tsuda, H., Hirohashi, S., Maeda, Y., Tsuruta, K., Miyaki, M. and Nakamura, Y. Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer. Cancer Res., 52, 5368-5372 (1992).
13. Takahashi, K., Kudo, J., Ishibashi, H., Hirata, Y. and Niho, Y. Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma. Hepatology, 17, 794-799 (1993).
14. Yeh, S. H., Chen, P. J., Chen, H. L., Lai, M. Y., Wang, C. C. and Chen, D. S. Frequent genetic alteration at the distal region of chromosome 1p in human hepatocellular carcinoma. Cancer Res., 54, 4188-4192 (1994).
15. De Souza, A. T., Hankins, G. R., Washington, M. K., Orton, T. C. and Jirtle, R. L. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat. Genet., 11, 447-449 (1995).
16. Nagai, H., Pineau, P., Tiollais, P., Buendia. M. A. and Dejean, A. Comprehensive allelotyping of human hepatocellular carcinoma. Oncogene, 14, 2927-2933 (1997).
17. Vale'rie, B., Pierre, L. P., Pierre, F., Jean, F. F., Genevieve, M., Pierre, B., Paulette, B. S., Frederique, C., Anette, S., Sylviane, O. and Gilles, T. Concerted nonsyntenic allelic losses in hyperploid hepatocellular carcinoma as determined by a high-resolution allelotype. Cancer Res., 15, 1986-1990 (1997).
18. Piao, Z., Park, C., Park, J. H. and Kim, H. Allelotype analysis of hepatocellular carcinoma. Int. J. Cancer, 75, 29-33 (1998).
19. Shirahama, S., Ogura, K., Takami, H., Ito, K., Tohsen, T., Miyauchi, A. and Nakamura, Y. Mutational analysis of the RET proto-oncogene in 71 Japanese patients with medullar thyroid carcinoma. J. Hum. Genet., 43, 101-106 (1998).
20. Dib, C., Faure, S., Fizames, C., Samson, D., Drouot, N., Vignal, A., Millasseau, P., Marc, S., Hazan, J., Seboun, E., Lathrop, M., Gyapay, G., Morissette, J. and Weissenbach, J. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature, 380, 152-154 (1996).
21. Tsukamoto, K., Haruta, K., Shiba, T. and Emi, M. Isolation and mapping of a polymorphic CA repeat sequence at human interleukin 6 locus. J. Hum. Genet., 43, 71-72 (1998).
22. Iida, A., Isobe, R., Yoshimoto, M., Kasumi, F. and Emi, M. Localization of a breast cancer tumor-suppressor gene to a 3-cM interval within chromosomal region 16q22. Br. J. Cancer, 75, 264-267 (1997).
23. Hermanek, P., Sobin, L. A. and Sun, T. "TNM Classification of Malignant Tumors," 4th Ed., UICC (1987). Springer, Berlin.
24. Edmondson, H. and Steiner, P. Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies. Cancer, 7, 462-503 (1954).
25. Zhang, W., Hirohashi, S., Tsuda, H., Shimosato, Y., Yokota, J., Terada, M. and Sugimura, T. Frequent loss of heterozygosity on chromosomes 16 and 4 in human hepatocellular carcinoma. Jpn. J. Cancer Res., 81, 108-111 (1990).
26. Slagle, B. L., Zhou, Y. Z., Birchmeier, W. and Scorsone, K. A. Deletion of the E-cadherin gene in hepatitis B virus-positive Chinese hepatocellular carcinomas. Hepatology, 18, 757-762 (1993).
27. Slagle, B. L., Zhou, Y. Z. and Butel, J. S. Hepatitis B virus integration event in human chromosome 17p near the p53 gene identified the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas. Cancer Res., 51, 49-54 (1991).
28. Kanai, Y., Ushijima, S., Tsuda, H., Sakamoto, M., Sugimura, T. and Hirohashi, S. Aberrant DNA methylation on chromosome 16 is an early event in hepatocarcinogenesis. Jpn. J. Cancer Res., 87, 1210-1217 (1996).
29. Green, A. J., Smith, M. and Yates, J. R. Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nat. Genet., 6, 193-196 (1994).
30. Tachibana, M., Iwata, N., Watanabe, A., Nobukuni, Y., Ploplis, B. and Kajigaya, S. Assignment of the gene for a ubiquitin-conjugating enzyme (UBE2I) to human chromosome band 16p13.3 by in situ hybridization. Cytogenet. Cell Genet., 75, 222-223 (1996).
31. Sijbers, A. M., de Laat, W. L., Ariza, R. R., Biggerstaff, M., Wei, Y. F., Moggs, J. G., Carter, K. C., Shell, B. K., Evans, E., De Jong, M. C., Rademakers, S., De Rooij, J., Taspers, N. G. J., Hoeijmakers, J. H. J. and Wood, R. D. Xeroderma pigmentosum group F caused by a defect in a structure-specific DNA repair endonuclease. Cell, 86, 811-822 (1996).
32. Ozawa, K., Murakami, Y., Yokoyama, K., Soeda, E., Hoshino, S., Ui, M. and Hanaoka, F. Mapping of the human GSPT1 gene, a human homolog of the yeast GST1 gene, to chromosomal band 16p13.1. Somat. Cell Mol. Genet., 18, 189-194 (1992).
33. Endo, T. A., Masuhara, M., Yokouchi, M., Suzuki, R., Sakamoto, H., Mitsui, K., Matsumoto, A., Tanimura, S., Ohtsubo, M., Misawa, H., Miyazaki, T., Leonor, N., Taniguchi, T., Fujita, T., Kanakura, Y., Komiya, S. and Yoshimura, A. A new protein containing an SH2 domain that inhibits JAK kinases. Nature, 387, 921-924 (1997).
34. Naka, T., Narazaki, M., Hirata, M., Matsumoto, T., Minamoto, S., Aono, A., Nishimoto, N., Kajita, T., Taga, T., Yoshizaki, K., Akira, S. and Kishimoto, T. Structure and function of a new STAT-induced STAT inhibitor. Nature, 387, 924-929 (1997).
35. Kuroki, T., Fujiwara, Y., Tsuchiya, E., Nakamori, S., Imaoka, S., Kanematsu, T. and Nakamura, Y. Accumulation of genetic changes during development and progression of hepatocellular carcinoma: loss of heterozygosity on chromosome arm 1p occurs at early stage of hepatocarcinogenesis. Genes Chromosom. Cancer, 13, 163-167 (1995).
36. Marchio, A., Mebbeb, M., Pineau, P., Danglot, G., Tiollais, P., Bernheim, A. and Dejean, A. Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosom. Cancer, 18, 59-65 (1997).